| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/12/2012 | US20120010156 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 01/12/2012 | US20120010155 Gntiii expression in plants |
| 01/12/2012 | US20120010154 Cytotoxic Conjugates Having Neuropeptide Y Receptor Binding Compound |
| 01/12/2012 | US20120010153 Novel tumor-targeting compounds |
| 01/12/2012 | US20120010152 Targeting of Podoplanin with Lectin for Use in the Prevention and Treatment of Cancer |
| 01/12/2012 | US20120010151 Use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 01/12/2012 | US20120010150 Lactoferrin compositions and methods of wound treatment |
| 01/12/2012 | US20120010149 Peptide combination |
| 01/12/2012 | US20120010148 Combination therapies using nap |
| 01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
| 01/12/2012 | US20120010146 Composite containing collagen and elastin as a dermal expander and tissue filler |
| 01/12/2012 | US20120010145 Methods and Compositions for Delivery of Medicaments to the Lungs |
| 01/12/2012 | US20120010144 Peg-albumin composition having at least one protected thiol region as a platform for medications |
| 01/12/2012 | US20120010143 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof |
| 01/12/2012 | US20120010142 Natriuretic activities |
| 01/12/2012 | US20120010141 Method for stimulating wound healing |
| 01/12/2012 | US20120010140 Self-assembling peptides for regeneration and repair of neural tissue |
| 01/12/2012 | US20120010139 Thermal responsive composition for treating bone diseases |
| 01/12/2012 | US20120010138 Novel uses of vegfxxxb |
| 01/12/2012 | US20120010137 Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | US20120010134 Soluble non-depot insulin conjugates and uses thereof |
| 01/12/2012 | US20120010133 Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent |
| 01/12/2012 | US20120010132 Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 01/12/2012 | US20120010131 Novel cyclosporin analogues |
| 01/12/2012 | US20120010130 Composition for preventing virus infection comprising poly-gamma-glutamic acid |
| 01/12/2012 | US20120010127 Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120010125 Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders |
| 01/12/2012 | US20120010124 Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
| 01/12/2012 | US20120010123 Methods of treating metabolic disorders and cardiovascular diseases |
| 01/12/2012 | US20120009648 DNA polymerase lambda and uses thereof |
| 01/12/2012 | US20120009267 Nanoparticle compositions and methods for improved oral delivery of active agents |
| 01/12/2012 | US20120009260 Nanoparticle film delivery systems |
| 01/12/2012 | US20120009248 Preservation of Bioactive Materials By Spray Drying |
| 01/12/2012 | US20120009245 Administration of Growth Factors for the Treatment of CNS Disorders |
| 01/12/2012 | US20120009243 Liposomes for drug delivery and methods for preparation thereof |
| 01/12/2012 | US20120009237 Wound healing compositions containing keratin biomaterials |
| 01/12/2012 | US20120009229 Pharmaceutical compositions and related methods of delivery |
| 01/12/2012 | US20120009225 Stable Solid Formulation of Therapeutic Polypeptides Suitable for Oral Administration |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009175 Method of Using Salmon Thrombin to Alleviate Pain |
| 01/12/2012 | US20120009174 Biomarkers for myocardial ischemia |
| 01/12/2012 | US20120009173 Cytotoxic ribonuclease variants |
| 01/12/2012 | US20120009172 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 01/12/2012 | US20120009171 Methods and compositions for cns delivery of arylsulfatase a |
| 01/12/2012 | US20120009170 METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009168 Improved emulsifying system for nutraceutical compositions |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120009150 Diaryl ureas for treating virus infections |
| 01/12/2012 | US20120009149 Tetrameric Cytokines with Improved Biological Activity |
| 01/12/2012 | US20120009148 Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection |
| 01/12/2012 | US20120009147 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 01/12/2012 | US20120009146 Treatment and Diagnostic Methods for Fibrosis Related Disorders |
| 01/12/2012 | US20120009145 Biodegradable Cross-Linked Cationic Multi-block Copolymers for Gene Delivery and Methods of Making Thereof |
| 01/12/2012 | US20120009144 Heterocyclic antiviral compounds |
| 01/12/2012 | US20120009143 Treating non-hematopoietic cancer with interleukin 6 |
| 01/12/2012 | US20120009142 Methods for treating hepatitis c |
| 01/12/2012 | US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 01/12/2012 | US20120009140 Compostition and therapeutic anti-tumour vaccine |
| 01/12/2012 | US20120009139 Methods and Compositions for Promoting Organ Development |
| 01/12/2012 | US20120009125 Apoe4 and apoj biomarker-based prevention and treatment of dementia |
| 01/12/2012 | US20120009123 Albumin binding peptide-mediated disease targeting |
| 01/12/2012 | DE112009001815T5 Herstellungsverfahren für bioabbaubare Mikropartikel, welche Arzneistoffe enthalten Contain manufacturing method for biodegradable microparticles which drugs |
| 01/12/2012 | DE102010026500A1 Verfahren zur Herstellung von autologen Proteinen Process for the preparation of autologous proteins |
| 01/12/2012 | CA2839677A1 Analogs of c5a and methods of using same |
| 01/12/2012 | CA2810170A1 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | CA2805557A1 Method of producing recombinant high molecular weight vwf in cell culture |
| 01/12/2012 | CA2805031A1 Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of insulin |
| 01/12/2012 | CA2804815A1 Nucleic acid delivery composition and carrier composition, pharmaceutical composition using the same, and method for nucleic acid delivery |
| 01/12/2012 | CA2804789A1 Pkc activators and anticoagulant in regimen for treating stroke |
| 01/12/2012 | CA2804618A1 Stabilized insulinotropic peptides and methods of use |
| 01/12/2012 | CA2804404A1 Methods for reducing oxidative damage |
| 01/12/2012 | CA2804280A1 Chimeric clotting factors |
| 01/12/2012 | CA2804275A1 Method of producing recombinant adamts13 in cell culture |
| 01/12/2012 | CA2804274A1 Factor ix polypeptides and methods of use thereof |
| 01/12/2012 | CA2803787A1 Adenovirus ad36 e4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2404934A1 Protease resistant insulin analogues |
| 01/11/2012 | EP2404932A1 Polypeptides and antibacterial or antiseptic use of same |
| 01/11/2012 | EP2404613A1 Novel uses of fibrinogen-420 and active domain thereof |
| 01/11/2012 | EP2404612A1 Diagnosis, prophylaxis and therapy of Alzheimer's disease and other neurodementing disorders |
| 01/11/2012 | EP2404611A1 Peptide for the prophylactic or therapeutic treatment of skin tumours in initial stages |
| 01/11/2012 | EP2404610A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
| 01/11/2012 | EP2403938A1 Method and material for site activated complexing of biologic molecules |
| 01/11/2012 | EP2403937A2 Methods of inhibiting photoreceptor apoptosis |
| 01/11/2012 | EP2403870A1 Peptides derived from ficolin as surfactants |
| 01/11/2012 | EP2403869A1 Peptides used for treating cancers and, in particular, chronic lymphoid leukaemia |
| 01/11/2012 | EP2403864A2 Polypeptide structural motifs associated with cell signaling activity |
| 01/11/2012 | EP2403523A1 Temperature sensitive mutants of matrix metalloprotease 1 und uses thereof |
| 01/11/2012 | EP2403522A1 Clostridial toxin to improve ejaculate |
| 01/11/2012 | EP2403521A1 Novel uses of fibrinogen |
| 01/11/2012 | EP2403520A1 Insulin formulations for rapid uptake |
| 01/11/2012 | EP2403519A1 Method for preventing and treating hyperpermeability |
| 01/11/2012 | EP2403518A2 Compositions and methods for modulation of cell migration |
| 01/11/2012 | EP2403517A1 Novel antiviral agent |